abstract |
The present invention is directed to benzamide containing compounds of formula I, which inhibit the P2X7 receptor. In other aspects, the invention is directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat pain, inflammation, neurological disorders, or neuropsychiatric disorders. (see formula I) |